Clinical Trial

A Randomized Phase III Study Comparing Maintenance Treatment With Fluoropyrimidine + Bevacizumab Versus Fluoropyrimidine After Induction Chemotherapy for a Metastatic Colorectal Cancer

Study acronym: BEVAMAINT
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The aim of BEVAMAINT is to improve benefic effect of maintenance therapy after a first line of induction chemotherapy for patients with colorectal cancer
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2019-12-03; most recent amendment 2026-07-15.
Status change: Recruiting → Active, Not Recruiting 2026-07-15
Status change: Not Yet Recruiting → Recruiting 2021-10-21
Trial Details
NCT Number NCT04188145
Lead Sponsor Centre Hospitalier Universitaire Dijon
Conditions Metastatic Colorectal Cancer
Enrollment 400 participants
Start Date 2020-01-27
Primary Completion 2029-09 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-16